Has Jessica Decourcey received payments from drug or device companies?

Yes. Drug and device makers reported $2,334 in general payments to Jessica Decourcey across 109 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Jessica Decourcey did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Jessica Decourcey come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Jessica Decourcey

Medical · Vernon, NYNPI 1609431006

Payments from drug & device makers

$2,334in general payments, 2019–2025

Across 109 payments — averaging $21.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$381
Pfizer$333
Novo Nordisk$322
AstraZeneca$283
AbbVie$243
Hologic Sales And Service, LLC$148
plus $623 from 12 others

What the payments were for

Food & beverage$2,334100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	24	$381
Pfizer	19	$333
Novo Nordisk	11	$322
AstraZeneca	15	$283
AbbVie	8	$243
Hologic Sales And Service, LLC	1	$148
Sanofi-aventis U.S. LLC	1	$116
Merck	5	$89
GSK	5	$83
Biohaven Pharmaceuticals, Inc.	3	$61
Arbor Pharmaceuticals, Inc.	4	$51
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC	3	$48
Sanofi Pasteur Inc.	2	$44
E.r. Squibb & Sons, L.L.C.	2	$30
Amgen	2	$29
Biohaven Pharmaceutical Holding Company Ltd.	1	$27
Boehringer Ingelheim	2	$24
Xeris Pharmaceuticals, Inc.	1	$22

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,334 in reported general payments places this provider in the 80th percentile of 2,395 medical providers in New York.

See all medical providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
EliquisApixaban	36	$35,683
FarxigaDapagliflozin Propanediol	26	$31,903
OzempicSemaglutide	22	$28,076
JardianceEmpagliflozin	21	$27,029
XareltoRivaroxaban	23	$21,308
Trelegy ElliptaFluticasone/Umeclidin/Vilanter	27	$17,273
MounjaroTirzepatide	13	$13,339
TrulicityDulaglutide	12	$10,774
BreynaBudesonide/Formoterol Fumarate	19	$3,167
Albuterol Sulfate HfaAlbuterol Sulfate	67	$2,385
Atorvastatin Calcium	219	$1,895
Lantus SolostarInsulin Glargine,hum.Rec.Anlog	18	$1,713
Omeprazole	100	$1,479
Levothyroxine Sodium	130	$1,380
Clobetasol EmollientClobetasol Propionate/Emoll	12	$996

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
PfizerEliquis	$333	$35,68336 claims
AstraZenecaFarxiga	$283	$31,90326 claims
Novo NordiskOzempic	$322	$28,07622 claims
Boehringer IngelheimJardiance	$24	$27,02921 claims
Lilly USA, LLCMounjaro, Trulicity	$381	$24,11325 claims
GSKTrelegy Ellipta	$83	$17,27327 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,395 medical providers in New York.

Other medical in Vernon

Rebecca EllwoodAlbany$565K
Denisse SerranoCortlandt Manor$255K
Michele Kissous-HuntNew York$246K
Laura MaroldoNew York$126K
Carl ClarkeBrooklyn$116K
Maureen ThyneNew York$109K
Gina FriesRochester$106K
Ilse StraussSmithtown$87K
Helen AdamsNew York$87K
Hailey BrickmanNew York$82K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →